Audra Savickaite

Principal Consultant | In-house Legal

US

• Banking and financial services
• Corporate and commercial
• In-house
• Principal Consultant

• +1 773 936 7560
• [email protected]
• Connect on LinkedIn

Audra partners with buy-side firms across the capital structure- from control equity sponsors and direct lenders to multi-asset platforms- to build high-performing legal teams in finance, operations, and investor services.

Based in Chicago, she brings nearly a decade of executive search experience across both public and private companies, PE-backed platforms, REITs, and institutional asset managers. Her placements are largely in leadership roles across legal, finance and investor services in real estate, industrials, and asset management. Audra is a trusted advisor known for her consultative, hands-on approach.

Related content

View all

Where are regional businesses struggling to hire lawyers?

• Posted September 22, 2026

Contents Share Key insights The UK regional in-house legal market continues to evolve at pace. Over the last decade, businesses across Manchester, Birmingham, Leeds and other regional centres have invested heavily in legal capability, creating increasingly sophisticated legal functions outside London.  While this growth has created exciting opportunities for lawyers, it has also intensified talent competition. Many employers are finding […]

From General Counsel to CEO: how legal leaders can make the leap

• Posted September 22, 2026

Contents Share Key insights Katherine Potter (Katie) has led a public company as CEO and served as General Counsel in listed and private equity-backed businesses. She explains why the move from legal adviser to business leader starts long before the title changes, and what ambitious GCs can do now to prepare for it. For many […]

How tech and life sciences companies should hire legal leaders for growth

• Posted September 4, 2026

Contents Share Key insights High-growth companies rarely need the same legal function for long.  A technology startup may initially need support with intellectual property and commercial contracts before enterprise growth, AI adoption or international expansion changes the legal brief. A life sciences company may move from fundraising and IP protection into clinical development, licensing and commercialization.  The challenge is recognising when […]